Dangerous Drugs - Ketek

Ketek, otherwise known as Telithromycin, is a popular antibiotic used to treat acute bacterial infections stemming from bronchitis, sinusitis and pneumonia. It was approved for use by the FDA in 2004. In its first two years on the market, Ketek was associated with a dozen cases of severe liver problems that included four deaths, the first of which occurred in January 2005. One year later, federal regulators decided to investigate an unknown number of cases regarding Ketek, and in December 2006, a panel of FDA advisors met to make a final decision on the controversial drug.

Despite allegations of fraudelent data on the drug's initial approval application, more than a dozen cases of liver failure, at least four deaths, and an incidence of blurry vision for 1 out of every 100 patients, the panel left Ketek on the market, advising that its sinitis and bronchitis indications be removed and the drug only be prescribed for patients battling pneumonia.

If you or a loved one has suffered an injury, illness or death, that seems to have been someone else's fault, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.